•He completed a Bachelor's in pharmacy from Jamia Hamdard University (New Delhi) in 2011 and Master's in Pharmacy (Pharmaceutics) from APJ Abdul Kalam Technical University (Noida) and International Islamic University Malaysia (Kuantan) in a sandwich program, which was completed in 2013. He also holds a post-graduate diploma in Pharmaceutical Drug Regulatory Affairs from Jamia Hamdard (New Delhi, 2012). •He completed his PhD from the International Islamic University Malaysia (Kuantan) in 2017. His PhD research was on drug delivery and technologies. For his PhD, he received a prestigious Islamic Development Bank scholarship. • After his PhD, he worked at University Malaysia Pahang as a senior lecturer teaching in the pharmaceutical engineering department. •His specialization is on the field of pharmaceutical technology and engineering, which includes (drug delivery, pharmacokinetics, pharmaceutical nanotechnology (nanoparticles mediated drug delivery), animal model, analytical chemistry (LC-MS, HPLC), and system validation and qualification. •Currently, he is working at Universiti Malaya in the pharmacy faculty attached to the pharmaceutical technology department.      

Dr. UZAIR ISHTIAQ received master’s degree in Computer Science from NUCES Islamabad, Pakistan, and the Ph.D. degree Faculty of Computer Science and Information Technology, Universiti Malaya, Malaysia. He worked as a Lecturer at COMSATS University Islamabad for more than 10 years and has been Senior Lecturer with the Department of Artificial Intelligence, FCSIT, Universiti Malaya, Malaysia, since 2025. He has published several articles in academic journals indexed in ISI and Scopus.

Dr. Chee is a Senior Lecturer at the Nanotechnology and Catalysis Research Centre, Universiti Malaya, where he earned his Ph.D. in organic chemistry in 2011. With a strong commitment to advancing scientific knowledge and solving complex challenges, he actively encourages collaboration to drive meaningful outcomes. Prior to joining academia, he was a senior scientist at Aurigene Discovery Technologies, and a research associate at Cancer Research Malaysia. He has been a visiting scholar at Harvard University in 2016, and the University of New South Wales in 2008. Throughout his career, he has been engaged in diversed research teams, fostering an environment for open communication and mutual respect. His research primarily focuses on drug discovery, medicinal chemistry and small molecules synthesis. Additionally, he passionately explores biomaterials, drug delivery and nanomedicine, with a special emphasis on developing small molecules for the treatment of cancer and microbial infections. He sincerely welcomes opportunities with like-minded individuals and research groups. He believes that through diverse perspectives and collective efforts, groundbreaking advancements can be achieved in the field of drug discovery.